Rimon is proud to congratulate our extraordinary clients, Warren Zevon and Soundgarden, on their inductions into the Rock & Roll Hall of Fame. Artists or bands become eligible for nomination for induction 25 years after releasing their first commercial recording. The selection criteria include an artist’s impact on music culture, influence on other musicians that have…

Rimon is proud to announce that Partner Debbie Klis has been named in the Top 25 Financial Services and Insurance Attorneys of 2025 by Attorney Intel. Attorneys named to the Top 25 list were selected through a methodical process and careful consideration of their career track records and industry contributions. Read the full story on…

Congratulations to Rimon attorneys Ken Anderson, Jill Berliner, Ray Garcia, Mark Lee, and Celeste Moy who have been recognized on the 2025 Billboard Top Music Lawyers list. As featured in the article: Rimon boasts a star-studded roster of clients, including iconic bands like Soundgarden, Foo Fighters and Nirvana, as well as entities affiliated with late…

We’re proud to announce the promotion of Sarah Challen McKee to Partner. Her dedication, insight, and contributions have been invaluable to the Rimon team, and we’re excited to see her continue to grow in this new role. Congratulations, Sarah! Sarah Challen McKee advises institutional investors, asset managers and investment funds on a wide range of…

San Francisco, CA — Rimon, P.C. is proud to announce its inclusion in the 2025 edition of U.S. News and World Reports and Best Lawyers® list of Best Companies to Work For: Law Firms ratings. This recognition is a reflection of our incredible attorneys whose talent and dedication make Rimon a truly distinct and innovative…

We congratulate our client, Neuphoria Therapeutics Inc. on their successful redomiciliation to the U.S. In celebratory fashion, Neuphoria Therapeutics Inc. rang the Nasdaq Opening Bell on March 3rd, 2025!  Ted Ghorra, Andrew Reilly, Elaine Wangsawidjaja and Olivia Wang have worked regularly with this client. Read more here Rimon’s Securities and Capital Markets attorneys have decades…

Cyclacel Pharmaceuticals, Inc. (“Cyclacel”) (NASDAQ: CYCC, NASDAQ: CYCCP), a biopharmaceutical company that develops innovative cancer medicines,  announced a change in control and leadership on February 26, 2025. Datuk Dr. Doris Wong Sing Ee acquired the majority interest in Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) and will now serve as its Chief Executive Officer and Executive Director. In…

Rimon SPAC client  Arogo Capital Acquisition Corp., announced that it has executed a business combination agreement with Bangkok Tellink Co., Ltd. Bangkok Tellink Co., Ltd. is an emerging leader in advanced telecommunications, mobile network technology, and Internet of Things (IoT) solutions. The transaction is estimated to be valued at USD$350 million and is expected to result…

We’re excited to announce the promotion of Swati Samanth to Counsel. Her commitment and expertise have been integral to Rimon’s team, and we look forward to seeing her thrive in this new role. Congratulations, Swati! Swati Samanth is an associate in Rimon’s San Francisco office where her practice focuses on Intellectual Property. She brings over…

The Russian Government is moving ahead with long delayed implementation of Decree of the President of Russia No. 422 dated May 23, 2024. The Decree calls for legal actions against governments of countries that seized the assets of Russia or the Bank of Russia. Private companies and individuals from such countries may be named co-defendants…